Shanghai Jiatan Pharmatech Co., Ltd
Shanghai Jiatan Pharmatech Co., Ltd
Explore linked clinical trials.7 results · Page 1 of 1
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| A Phase III Clinical Study of WX390 Combined With Toripalimab Versus Investigator's Choice of Therapy in Patients With Recurrent or Metastatic Cervical Cancer Who Have Failed Prior Platinum-Based Treatment | Cervical Cancer Metastatic | Not yet recruiting | Phase 3 | 2026-02-06 | NCT07392060 | |
| A Phase III Study of Oral Sudapyridine (WX-081) Tablets in Rifampicin-Resistant Pulmonary Tuberculosis Patients | Actinomycetales infectious disease, Bacterial Infections and Mycoses, Infections, bacterial infectious disease, gram-positive bacterial infections, lung disorder, multidrug-resistant tuberculosis, mycobacterial infectious disease, pulmonary tuberculosis, respiratory system disorder, respiratory tract infectious disorder, tuberculosis | Recruiting | Phase 3 | 2025-06-29 | NCT05824871 | |
| Drug-Drug Interaction and Food Effect of Sudapyridine(WX-081) With Itraconazole and Rifampin in Healthy Chinese Adults | Rifampicin-Resistant Pulmonary Tuberculosis Patients | Not yet recruiting | Phase 1 | 2025-02-12 | NCT06701136 | |
| A Study of WX390 Combined With Toripalimab in Patients With Advanced Gastric-type Endocervical Adenocarcinoma With STK11 Mutations | Gastric Type Adenocarcinoma (GAS) With STK11 Mutation | Recruiting | Phase 2 | 2024-12-10 | NCT06124963 | |
| A Study of WX390 Combined With Toripalimab in Patients With Advanced Solid Tumors | Solid Tumor | Recruiting | Phase 1 / Phase 2 | 2024-11-25 | NCT06117566 | |
| Pharmacokinetic Study of Sudapyridine（WX-081）in Healthy Chinese Subjects | TB | Recruiting | Phase 1 | 2024-11-22 | NCT06701110 | |
| A Study of WX390 in Patients With Advanced Solid Tumors | Solid Tumor | Recruiting | Phase 2 | 2024-11-19 | NCT06117540 |